Drug Development for Neglected Diseases
From PHM Oz
(Difference between revisions)
DavidLegge (Talk | contribs) |
DavidLegge (Talk | contribs) |
||
| Line 3: | Line 3: | ||
WHO Commission on Intellectual Property Rights, Innovation and Public Health (2.73mb)[[http://www.who.int/intellectualproperty/report/en/]] | WHO Commission on Intellectual Property Rights, Innovation and Public Health (2.73mb)[[http://www.who.int/intellectualproperty/report/en/]] | ||
| − | Medical Innovation Prize Fund Proposal (James Love)[[http://www.cptech.org/ip/health/prizefund/ | + | Medical Innovation Prize Fund Proposal (James Love)[[http://www.cptech.org/ip/health/prizefund/]] |
[[Intellectual Property and Pharmaceuticals|Back to IP home]] | [[Intellectual Property and Pharmaceuticals|Back to IP home]] | ||
Revision as of 03:51, 9 July 2007
Drugs for Neglected Diseases Initiative (DNDI)[[1]]
WHO Commission on Intellectual Property Rights, Innovation and Public Health (2.73mb)[[2]]
Medical Innovation Prize Fund Proposal (James Love)[[3]]
